IP Library Granted Patent US 8,367,335
Granted Patent B2
US 8,367,335 · App. 13/441,186 · Granted Feb 5, 2013

Programmable oligonucleotide synthesis

Inventors: Peer Staehler (Mannheim, DE); Raphael Carapito (Strasbourg, FR)
Assignee: Synthetic Genomics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,335
App. No.
13/441,186
Granted
Feb 5, 2013
Kind
B2
Abstract

The invention relates to methods and devices for preparing synthetic nucleic acids.

Claims (58)

1. A method for isolating an individual nucleic acid molecule having a desired correct sequence from a mixture of nucleic acids, comprising:

(a) monoclonizing a mixture of nucleic acids on a solid reaction support;

(b) parallel sequencing the monoclonized nucleic acids of step (a),

(c) localizing a nucleic acid molecule with the desired correct sequence in the nucleic acids of step (b),

(d) isolating the nucleic acid molecule from step (c), and

(e) optionally further processing of the isolated nucleic acid molecule obtained in step (d).

2. A method for isolating an individual nucleic acid having a desired sequence from a mixture of nucleic acids, comprising:

(a) monoclonizing a mixture of nucleic acids on a solid reaction support;

(b) parallel sequencing the monoclonized nucleic acids of step (a),

(c) localizing a nucleic acid with the desired sequence in the nucleic acids of step (b),

(d) isolating the nucleic acid from step (c), and

(e) optionally further processing of isolated nucleic acid obtained in step (d) wherein the isolation takes place by at least one of steps (i) to (iv):

(i) isolating one or more beads on which said nucleic acid molecule is immobilized,

(ii) cleaving off the nucleic acid molecule from a support on which said nucleic acid molecule is immobilized,

(iii) selectively amplifying the nucleic acid molecule by spatially-resolved addition of PCR reagents,

(iv) eluting the nucleic acid molecule by laser capture method.

3. A method for isolating an individual nucleic acid molecule having a desired correct sequence from a mixture of nucleic acids, comprising:

(a) monoclonizing a plurality of the different nucleic acids by emulsion-based PCR on beads

(b) immobilizing the beads in a reaction support

(c) parallel sequencing the monoclonized nucleic acids of step (a)

(d) localizing an individual nucleic acid molecule with the desired correct sequence in the nucleic acids of step (c)

(e) isolating the beads comprising the nucleic acid molecules localized in step (d)

(f) obtaining the clonal nucleic acid sequences by detachment of the clonal nucleic acid sequence from the bead or by copying

(f) optionally further processing of the isolated nucleic acid molecule obtained in step (d).

4. A method for quality control of assembled nucleic acid molecules, said method comprising:

(a) providing a mixture of assembled nucleic acid molecules suspected of containing sequence defects,

(b) amplifying the mixture of (a) to receive a clonal population thereof,

(c) immobilizing the clonal population of (b) on a support,

(d) parallel sequencing the clonal population immobilized according to (c),

(e) localizing at least one clonal nucleic acid molecule that meets a predefined criterion

(f) obtaining the at least one clonal nucleic acid molecule of (e).

5. A method for isolation of a sequence-verified nucleic acid clone, comprising:

(a) providing a mixture of nucleic acid molecules suspected of containing sequence defects,

(b) amplifying the mixture of (a) to receive a clonal population thereof,

(c) immobilizing the clonal population of (b) on a support,

(d) parallel sequencing the clonal population immobilized according to (c)

(e) localizing at least one clonal nucleic acid molecule that meets a predefined criterion, and

(f) obtaining the at least one clonal nucleic acid molecule of (e).

6. The method of claim 4 , wherein the assembled sequences provided in step (a) are built each from one or more oligonucleotides.

7. The method of claim 4 , wherein the assembled sequences represent genes, gene clusters, chromosomes, genomes or fragments thereof.

8. The method of claim 4 , wherein amplification in step (b) comprises an emulsion-based PCR.

9. The method of claim 4 , wherein immobilizing the clonal population according to step (c) comprises immobilization on beads.

10. The method of claim 4 , wherein the predetermined criterion in step (e) is the desired correct sequence.

11. The method of claim 4 , wherein the obtaining the clonal nucleic acid molecule of (f) comprises at least one of:

(i) detachment of the clonal nucleic acid molecule from the support,

(ii) copying of the clonal nucleic acid molecule,

(iii) laser capture, or/and

(iv) amplification by spatially resolved PCR.

12. A method of assembly of nucleic acid molecules comprising:

(i) providing single-stranded nucleic acid molecules to be assembled into a target nucleic acid molecule,

(ii) assembling by hybridization complementary regions of the single-strands nucleic acids of (i),

(iii) controlling the quality of the mixture of assembled nucleic acid molecules obtained in step (ii) by the method of claim 4 .

13. The method of claim 12 , wherein step (ii) results in a gene, gene cluster, chromosome, genome or a fragment thereof.

14. The method of claim 1 wherein the further processing comprises assembling nucleic acid molecules of step (d) to a desired nucleic acid.

15. The method of claim 1 wherein the solid reaction support is selected from the group consisting of: one or more beads, one or more particles, one or more chips, and a microfluidic reaction support.

16. The method of claim 15 wherein the solid reaction support is one or more beads or a chip.

17. The method of claim 5 wherein the solid reaction support is selected from the group consisting of: one or more beads, one or more particles, one or more chips, and a microfluidic reaction support.

18. The method of claim 17 wherein the solid reaction support is one or more beads or a chip.

Assignments (9)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2012
From: FEBIT HOLDING GMBH
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 028814/0354 →
Priority Claims (1)
DE 10 2006 039 479 · Aug 23, 2006 · national
Continuity (2)
Division 12438425
Related Publication 20120196757A1 · Aug 2, 2012